low toxic paclitaxel derivative (Amplyx)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namelow toxic paclitaxel derivative (Amplyx)
Drug Alias Nametaxane derivative (Amplyx Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFK506 binding protein modulators
TargetsFK506 binding protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmplyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmplyx Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A